The observed increase in ECM1 levels within the tumor can be attributed to multiple factors, including the enhanced delivery of ECM1 by sEVs to the tumor, increased release of ECM1 from tumor cells, and elevated levels of ECM1 present in sEVs within the tumor microenvironment. Here, ECM1 is linked to neoplasm.